Chewy Inc.'s stock rose 4.9% early Tuesday after the online pet-product retailer blew past earnings estimates for the fourth quarter, buoyed by strong customer growth. The activist investor is trying ...
Pfizer's stock is poised for growth due to its strong pipeline, smart cost management, and recovery from COVID-19 revenue ...
Pfizer’s buyout of Seagen was among the issues Starboard Value pointed to in October of last year when it called on the company’s board to “hold management accountable” for what it ...
Arvinas and Pfizer’s targeted protein degrader has not managed to distinguish itself from other, similar breast cancer drugs, according to pivotal data re ...
The company named two new directors to the board several weeks later. In July Starboard Value, another activist investor, was urging Match to consider a sale if it could not revitalize the business.
Despite facing legal challenges and investor pressure, such as litigation related to Oxbryta and interactions with activist investor Starboard, Pfizer has remained resilient. Its strategic ...
Pfizer and Arvinas’ estrogen receptor (ER) degrader has failed a key part of its first phase 3 test, although the companies have pointed to success in a subpopulation to suggest the therapy ...
Karen Molinar, the newly appointed superintendent of the Fort Worth Independent School District, speaks to the community members in attendance during the third FWISD community meeting to discuss ...
Arvinas’ stock took a 43% tumble on the news, and analysts are downcast on the drug’s prospects. Pfizer and Arvinas’ investigational PRTOAC degrader vepdegestrant can improve progression-free survival ...
THE WHAT? Kenvue, the consumer health company behind skin care and beauty brands like Neutrogena and Aveeno, has settled a months-long proxy fight with activist investor Starboard Value. As part of ...
Starboard’s Kenvue saga came shortly after it picked up a $1 billion stake in Pfizer and initiated a proxy fight with the New York-based drugmaker. However, after criticizing the company’s R&D ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback